Načítá se...

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD

BACKGROUND: The ability of a long-acting muscarinic antagonist (LAMA) and long-acting beta 2 agonists (LABAs; long-acting bronchodilators, LABDs) with or without inhaled corticosteroids (ICSs) to reduce early readmission in hospitalized patients with COPD is unknown. METHODS: We studied a 5% sample...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Chron Obstruct Pulmon Dis
Hlavní autoři: Bishwakarma, Raju, Zhang, Wei, Kuo, Yong-Fang, Sharma, Gulshan
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5293361/
https://ncbi.nlm.nih.gov/pubmed/28203071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S122354
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!